問卷

TPIDB > Principal Investigator

Principal Investigator


National Taiwan University Hospital (在職)

Division of Otolaryngology

Division of Hematology & Oncology

更新時間:2024-03-18

婁培人Lou, Pei-Jen
  • Principal Investigator
  • Clinical Trial Experience (year) 17 years 9 個月

Highlights

1. Steering committee member of “Phase 3, Randomized, Double-Arm, Open-Label, controlled Trial of ASP-1929 Photoimmunotherapy Versus Physician’s Choice Standard of Care for the Treatment of Locoregional, Recurrent Head and Neck Squamous Cell Carcinoma in Patients Who Have Failed or Progressed On or After at Least Two Lines of Therapy, of Which at Least One Line Must be Systemic Therapy” and “Phase 2 Single-arm Study of ASP-1929 Photoimmunotherapy Combined With Pembrolizumab in Patients With Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck, With or Without Metastases, Not Amenable to Curative Local Treatment”
2. International Advisory Board Member for head and neck cancer (MSD and Rakuten Medical)
3. Cooperated with more than 40 international organizations for head and cancer treatment (Lancet Oncol 2020; 21(7):e350-e359. doi: 10.1016/S1470-2045(20)30334-X.)

Study Area

  • Head and Neck Cancer

Professional Experiences

National Taiwan University Hospital

Vice Superintendent

-

National Taiwan University, College of Medicine

Professor

Department of Otolaryngology

National Taiwan University, College of Medicine

Professor

Department of Anatomy and Cell Biology

National Taiwan University Hospital

Attending Physician

Department of Otolaryngology

Education

National Taiwan University

Graduate Institute of Anatomy and Cell Biology, College of Medicine

Ph.D.

Clinical Trials List

See All35Cases

2016

Total 35

  • I 4

  • I/II 1

  • II 4

  • II/III 5

  • III 18

  • IV 0

  • Others 3

Number of Studies by Scale

2件

Taiwan Multiple Center

Taiwan Single Center

3Cases

Taiwan Multiple Center

2Cases

Multi-Regional Multi-Center

35Cases